Kyowa Kirin
Kyowa Kirin, Inc.
135 Route 202/206, Suite 6
Bedminster, NJ 07921
Phone: (908) 234 1096Website: https://kyowa-kirin.com/Careers: kyowa-kirin.com/careers/index.html
Latest news
- FDA Approves Nourianz (istradefylline) as an Add-On Drug to Treat Off Episodes in Adults with Parkinson’s Disease
28 August 2019 - Kyowa Kirin Announces FDA Acceptance of Istradefylline (KW-6002) New Drug Application Resubmission in the US
4 April 2019 - FDA Approves Poteligeo (mogamulizumab-kpkc) for Mycosis Fungoides and Sézary Syndrome
8 August 2018 - Kyowa Hakko Kirin Announces FDA Notification of PDUFA Action Date Extension for Mogamulizumab
30 May 2018 - Kyowa Hakko Kirin Announces FDA Acceptance for Filing and Priority Review Designation of Mogamulizumab Biologics License Application
28 November 2017 - FDA Grants Breakthrough Therapy Designation for Mogamulizumab for the Treatment of Mycosis Fungoides and Sézary Syndrome
25 August 2017 - Kyowa Hakko Receives Not Approvable Letter from FDA forIstradefylline (KW-6002)
28 February 2008 - Submission of NDA for Istradefylline (KW-6002), an Investigational Anti-Parkinson's Disease Drug
27 April 2007
Drugs Associated with Kyowa Kirin, Inc.
Kyowa Kirin, Inc. manufactures, markets and/or distributes more than 4 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Fareston
Generic name: toremifene Drug class: hormones/antineoplastics, selective estrogen receptor modulators |
||
|
Nourianz
Generic name: istradefylline Drug class: miscellaneous antiparkinson agents |
2 reviews | 8.0 / 10 |
|
Poteligeo
Generic name: mogamulizumab Drug class: miscellaneous antineoplastics |
||
|
Sancuso
Generic name: granisetron Drug class: 5HT3 receptor antagonists |
13 reviews | 6.4 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
